rel-(3R,4R)-tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate

 化学構造式
1163128-11-7
CAS番号.
1163128-11-7
化学名:
别名:
英語名:
rel-(3R,4R)-tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate
英語别名:
rel-(3R,4R)-tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate;1-Pyrrolidinecarboxylic acid, 3,4-dihydroxy-, 1,1-dimethylethyl ester, (3R,4R)-rel-
CBNumber:
CB23036893
化学式:
C9H17NO4
分子量:
203.24
MOL File:
1163128-11-7.mol

rel-(3R,4R)-tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate 物理性質

安全性情報

rel-(3R,4R)-tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

rel-(3R,4R)-tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate 化学特性,用途語,生産方法

rel-(3R,4R)-tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate 上流と下流の製品情報

原材料

準備製品


rel-(3R,4R)-tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate 生産企業

Global( 11)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Hangzhou FandaChem Co.,Ltd.
008657128800458; +8615858145714
fandachem@gmail.com China 9337 55
Chengdu Feibo Pharm Technology Co., Ltd
15982321820
abby@arkpharm.com CHINA 3279 58
NINGBOBENKANGJS PHARMTECHCO., LTD
+8615990591583 15990591583
CHINA 2029 58
Shanghai Tube Pharmaceutical Co., Ltd. 021-54338626 18017892860
sales@tubepharm.com China 2329 58
Chengdu Feibai Pharmaceutical Co., Ltd. 028-84641798 18782128315
3302391190@qq.com China 9970 55
Henan Pumei Jihua Pharmaceutical Technology Co., Ltd. 037188900765 18037465274
enyawanglei@sina.cn China 13639 58
Ningbo Benkang jishi Pharmaceutical Technology Co., Ltd. 15990591583
China 5575 58
Shanghai Sunway Pharmaceutical Technology Co.,Ltd. 021-51816796-820 13611835272
sales2@sunwaypharm.com China 44482 58
Hebei Yaocheng Pharmaceutical Technology Co. Ltd 0311-88802076 13171568381
info@yaochengph.com China 2115 58
Shanghai Haohong Scientific Co., Ltd. 400-400-8210725
malulu@leyan.com China 40041 58

1163128-11-7()キーワード:


  • 1163128-11-7
  • rel-(3R,4R)-tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate
  • 1-Pyrrolidinecarboxylic acid, 3,4-dihydroxy-, 1,1-dimethylethyl ester, (3R,4R)-rel-
Copyright 2017 © ChemicalBook. All rights reserved